Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jun 15, 2015
Emerging Company Profile

Maximizing immunogenicity

Why OncoQR thinks its S-TIR vaccine can work better than other cancer vaccines
BioCentury | Apr 23, 2012
Company News

TapImmune, Mayo Clinic deal

BioCentury | Jan 24, 2011
Clinical News

Nimotuzumab: Preliminary Phase II data

BioCentury | Jan 21, 2011
Clinical News

YM reports nimotuzumab data in gastric cancer

BioCentury | Aug 16, 2010
Strategy

PBMs become companions

Medco and CVS Caremark could boost sales of companion diagnostics
BioCentury | Jul 26, 2010
Company News

Leica Microsystems, Abbott deal

BioCentury | Jun 14, 2010
Product Development

All in the family

Next-generation EGFR inhibitors at ASCO: bigger blockade, more efficacy in cancer
BioCentury | Jan 29, 2010
Company News

EC approves Herceptin for stomach cancer

Items per page:
1 - 10 of 27